Literature DB >> 7312160

Cranial computed tomography of patients with malignant melanoma.

S Holtås, S Cronqvist.   

Abstract

Sixty-eight patients with malignant melanoma were examined by CCT and the findings analyzed. Cerebral metastases were detected in 19 patients. Meningiomas were found in three patients, one with neurological symptoms and two without. Typical metastases less than 10 mm in diameter were located superficially in the grey matter, regular, homogenous, hyperdense, with no edema. Extensive peripheral edema was often associated with metastases measuring more than 10 mm. CCT revealed cerebral metastases in 6 (13%) of 46 asymptomatic patients. The metastases measured less than 10 mm in four and less than 20 mm in two of these patients. Scintigraphy was falsely negative in six patients with metastases smaller than 10 mm. Therefore, CCT is the method of choice for screening asymptomatic patients. Angiography may be of value in the differentiation between meningioma and melanoma metastases.

Entities:  

Mesh:

Year:  1981        PMID: 7312160     DOI: 10.1007/bf00346752

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  8 in total

1.  One hundred intracranial meningiomas found incidentally at necropsy.

Authors:  M W WOOD; R J WHITE; J W KERNOHAN
Journal:  J Neuropathol Exp Neurol       Date:  1957-07       Impact factor: 3.685

2.  Natural history of malignant melanoma as related to therapy.

Authors:  V T DeVita; R I Fisher
Journal:  Cancer Treat Rep       Date:  1976-02

3.  The value of routine cranial computed tomography in neurologically intact patients with primary carcinoma of the lung.

Authors:  A R Butler; J S Leo; J P Lin; A D Boyd; I I Kricheff
Journal:  Radiology       Date:  1979-05       Impact factor: 11.105

4.  Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).

Authors:  D H Cowan; D E Bergsagel
Journal:  Cancer Chemother Rep       Date:  1971-04

5.  Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival.

Authors:  M H Amer; M Al-Sarraf; L H Baker; V K Vaitkevicius
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

6.  Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.

Authors:  D L Ahmann; R G Hahn; H F Bisel
Journal:  Cancer       Date:  1974-03       Impact factor: 6.860

7.  Symptoms of occult brain metastases initiated by systemic Dacarbazine (DTIC-DOME) therapy in melanoma patients.

Authors:  L Hafström; P E Jönsson
Journal:  Clin Oncol       Date:  1980-12

8.  Malignant melanoma metastatic to the central nervous system.

Authors:  D R Enzmann; R Kramer; D Norman; J Pollock
Journal:  Radiology       Date:  1978-04       Impact factor: 11.105

  8 in total
  4 in total

1.  Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B.

Authors:  Klaus Strobel; Reinhard Dummer; Hans C Steinert; Katrin Baumann Conzett; Karin Schad; Marisol Pérez Lago; Jan D Soyka; P Veit-Haibach; Burkhardt Seifert; V Kalff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-06       Impact factor: 9.236

2.  Computed tomography of malignant lymphoma of the brain.

Authors:  S Holtås; U Nyman; S Cronqvist
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

3.  Blood-fluid levels in multiloculated cystic brain metastasis of a hypernephroma. A case report.

Authors:  M C Kaiser; G Rodesch; P Capesius
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

4.  Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.

Authors:  Jacqueline Dinnes; Lavinia Ferrante di Ruffano; Yemisi Takwoingi; Seau Tak Cheung; Paul Nathan; Rubeta N Matin; Naomi Chuchu; Sue Ann Chan; Alana Durack; Susan E Bayliss; Abha Gulati; Lopa Patel; Clare Davenport; Kathie Godfrey; Manil Subesinghe; Zoe Traill; Jonathan J Deeks; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.